Medicare Will Be Leading Payer For Hepatitis C By 2017 – Milliman Report
This article was originally published in The Pink Sheet Daily
Executive Summary
Commissioned by Janssen Therapeutics, the report focuses on how a number of changes in the U.S. health care environment will increase access to diagnosis and treatment for patients with hepatitis C and also change who pays for care.